Abstract
Plant origin products having anticancer properties come into prominence due to widespread of cancer. Plumbagin has various biological activities like anticancer activity. Estrogen receptor (ER) specificity of plumbagin (PL) and radiolabeled PL investigated by in vitro studies on ER+ and ER− adenocarcinoma cells. Additionally, PLGA encapsulation was carried out to reduce toxicity of plumbagin and encapsulation effect was investigated. Plumbagin radiolabeled with 100 % in yields and had ER specificity. Furthermore, PLGA encapsulation effected positively on properties of plumbagin; reduced toxicity, increased stability and ER specificity. A promising agent for the diagnosis of ER+ breast cancer is suggested.
Similar content being viewed by others
References
Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64:9–29
Siegel RL, Miller KD, Jemal A (2015) Cancer statistics, 2015. CA Cancer J Clin 65:5–29
Padhye S, Dandawate P, Yusufi M, Ahmad A, Sarkar FH (2012) Perspectives on medicinal properties of plumbagin and its analogs. Med Res Rev 32:1131–1158
Onitilo AA, Engel JM, Greenlee RT, Mukesh BN (2009) Breast cancer subtypes based on ER/PR and Her2 expression: comparison of clinicopathologic features and survival. Clin Med Res 7:4–13
Van de Vijver MJ, He YD, van’t Veer LJ, Dai H, Hart AAM, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L, van der Velde T, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH, Bernards R (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347:1999–2009
Ozkan BM, Muftuler FZB, Kilcar AY, Medine EI, Unak P (2013) Isolation of hydroxytyrosol from olive leaves extract, radioiodination and investigation of bioaffinity using in vivo/in vitro methods. Radiochim Acta 101:585–593
Efferth T, Li PCH, Konkimalla VSB, Kaina B (2007) From traditional Chinese medicine to rational cancer therapy. Trends Mol Med 13:353–361
Gullett NP, Ruhul Amin ARM, Bayraktar S, Pezzuto JM, Shin DM, Khuri FR, Aggarwal BB, Surh YJ, Kucuk O (2010) Cancer prevention with natural compounds. Semin Oncol 37:258–281
Ghavami G, Sardari S, Shokrgozar MA (2010) Anticancerous potentials of Achillea species against selected cell lines. J Med Plants Res 4:2411–2417
Selvakumar V, Anbudurai PR, Balakumar T (2001) In vitro propagation of the medicinal plant Plumbago zeylanica L. through nodal explants. In Vitro Cell Dev Biol 37:280–284
Patil CD, Patil SV, Salunke BK, Salunkhe RB (2010) Bioefficacy of Plumbago zeylanica (Plumbaginaceae) and Cestrum nocturnum (Solanaceae) plant extracts against Aedes aegypti (Diptera: Culicide) and nontarget fish Poecilia reticulata. Parasitol Res 108:1253–1263
Pant M, Lal A, Rana S, Rani A (2012) Plumbago Zeylanica L.: a Mini Review. Int J Pharm Appl 3:399–405
Singh UV, Bisht KS, Rao S, Devi PU, Udupa N (1996) Plumbagin-loaded PLGA microspheres with reduced toxicity and enhanced antitumour efficacy in mice. Pharm Pharmacol Commun 2:407–440
Pandey U, Bapat K, Samuel G, Sarma HD, Venkatesh M (2007) Potential of radioiodinated anti cancer compounds of natural origin for cancer therapy. J Radioanal Nucl Chem 273:725–728
Mossa JS, El-Feraly FS, Muhammad I (2004) Antimycobacterial constituents from Juniperus procera, Ferula communis and Plumbago zeylanica and their in vitro synergistic activity with isonicotinic acid hydrazide. Phyther Res 18:934–937
Ding Y, Chen Z-J, Liu S, Che D, Vetter M, Chang CH (2005) Inhibition of Nox-4 activity by plumbagin, a plant-derived bioactive naphthoquinone. J Pharm Pharmacol 57:111–116
Aziz MH, Dreckschmidt NE, Verma AK (2008) Plumbagin, a medicinal plant-derived naphthoquinone, is a novel inhibitor of the growth and invasion of hormone-refractory prostate cancer. Cancer Res 68:9024–9032
Xu T-P, Shen H, Liu L-X, Shu Y-Q (2013) Plumbagin from Plumbago Zeylanica L induces apoptosis in human non-small cell lung cancer cell lines through NF-κB inactivation. Asian Pac J Cancer Prev 14:2325–2331
Sugie S, Okamoto K, Rahman KMW, Tanaka T, Kawai K, Yamahara J, Mori H (1998) Inhibitory effects of plumbagin and juglone on azoxymethane-induced intestinal carcinogenesis in rats. Cancer Lett 127:177–183
Kuo P-L, Hsu Y-L, Cho C-Y (2006) Plumbagin induces G2-M arrest and autophagy by inhibiting the AKT/mammalian target of rapamycin pathway in breast cancer cells. Mol Cancer Ther 5:3209–3221
Hsu Y-L, Cho C-Y, Kuo P-L, Huang YT, Lin CC (2006) Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH2-terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo. J Pharmacol Exp Ther 318:484–494
Hazra B, Sarkar R, Bhattacharyya S, Ghosh PK, Chel G, Dinda B (2002) Synthesis of plumbagin derivatives and their inhibitory activities against Ehrlich ascites carcinoma in vivo and Leishmania donovani promastigotes in vitro. Phytother Res 16:133–137
Xu K-H, Lu D-P (2010) Plumbagin induces ROS-mediated apoptosis in human promyelocytic leukemia cells in vivo. Leuk Res 34:658–665
Powolny AA, Singh SV (2008) Plumbagin-induced apoptosis in human prostate cancer cells is associated with modulation of cellular redox status and generation of reactive oxygen species. Pharm Res 25:2171–2180
Ahmad A, Banerjee S, Wang Z, Kong D, Sarkar FH (2008) Plumbagin-induced apoptosis of human breast cancer cells is mediated by inactivation of NF-κB and Bcl-2. J Cell Biochem 105:1461–1471
Thasni KA, Rakesh S, Rojini G, Ratheeshkumar T, Srinivas G, Priya S (2008) Estrogen-dependent cell signaling and apoptosis in BRCA1-blocked BG1 ovarian cancer cells in response to plumbagin and other chemotherapeutic agents. Ann Oncol 19:696–705
Wang CCC, Chiang Y-M, Sung S-C, Hsue Y-L, Chang JK, Kuo PL (2008) Plumbagin induces cell cycle arrest and apoptosis through reactive oxygen species/c-Jun N-terminal kinase pathways in human melanoma A375. S2 cells. Cancer Lett 259:82–98
Sinha S, Pal K, Elkhanany A, Dutta S, Cao Y, Mondal G, Iyer S, Somasundaram V, Couch FJ, Shridhar V, Bhattacharya R, Mukhopadhyay D, Srinivas P (2013) Plumbagin inhibits tumorigenesis and angiogenesis of ovarian cancer cells in vivo. Int J Cancer 132:1201–1212
Kawiak A, Piosik J, Stasilojc G, Gwizdek-Wisniewska A, Marczak L, Stobiecki M, Bigda J, Lojkowska E (2007) Induction of apoptosis by plumbagin through reactive oxygen species-mediated inhibition of topoisomerase II. Toxicol Appl Pharmacol 223:267–276
Sand JM, Bin Hafeez B, Jamal MS, Witkowsky O, Siebers EM, Fischer J, Verma AK (2012) Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone), isolated from Plumbago zeylanica, inhibits ultraviolet radiation-induced development of squamous cell carcinomas. Carcinogenesis 33:184–190
Parimala R, Sachdanandam P (1993) Effect of Plumbagin on some glucose metabolising enzymes studied in rats in experimental hepatoma. Mol Cell Biochem 125:59–63
Azad Chowdhury AK, Sushanta KC, Azad Khan AK (1982) Antifertility activity of Plumbago zeylanica Linn. root. Indian J Med Res 76:99–101
Brannon-Peppas L (1995) Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery. Int J Pharm 116:1–9
Peltonen L, Koistinen P, Karjalainen M, Hakkinen A, Hirvonen J (2002) The effect of cosolvents on the formulation of nanoparticles from low-molecular-weight poly(l) lactide. AAPS PharmSciTech 3(E32):1–7
Muhammad HM, Saour KY, Naqishbandi AM (2009) Quantitative and qualitative analysis of plumbagin in the leaf and root of Plumbago europaea growing naturally in Kurdistan by HPLC introduction. Iraqi J Pharm Sci 18:54–59
Zhen W, Han H, Anguiano M, Lemere CA, Cho CG, Lansbury PT (1999) Synthesis and amyloid binding properties of rhenium complexes: preliminary progress toward a reagent for SPECT imaging of Alzheimer’s disease brain. J Med Chem 42:2805–2815
Mele’ndez-Alafort LM, Riondato M, Nadali A, Mele L, Banzato A, Camporese D, Boccaccio P, Uzunov N, Rosato A, Mazzi U (2006) Bioavailability of 99mTc-Ha-paclitaxel complex [99mTc-ONCOFID-P] in mice using four different administration routes. J Label Compd Radiopharm 49:939–950
Mirahmadi N, Babaei MH, Vali AM, Daha FJ, Kobarfard F, Dadashzadeh S (2008) 99mTc-HMPAO-labeled liposomes: an investigation into the effects of some formulation factors on labeling efficiency and in vitro stability. Nucl Med Biol 35:387–392
Schwochau K (2000) Technetium chemistry and radiopharmaceutical applications. Wiley, Winheim
Nguyen AT, Malonne H, Duez P, Vanhaelen-Fastre R, Vanhaelen M, Fontaine J (2004) Cytotoxic constituents from Plumbago zeylanica. Fitoterapia 75:500–504
Bapat K, Chintalwar GJ, Pandey U, Thakur VS, Sarma HD, Samuel G, Pillai MRA, Chattopadhyay S, Meera Venkatesh (2005) Preparation and in vitro evaluation of radioiodinated bakuchiol as an anti tumor agent. Appl Radiat Isot 62:389–393
Acknowledgments
Current work is supported by Ege University Research Fund (contract no 2014 NBE 004). The authors thank to Büşra Karatay and Görkem Yıldız for the technical assistance during the assays.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yurt Kilcar, A., Tekin, V., Biber Muftuler, F.Z. et al. 99mTc labeled plumbagin: estrogen receptor dependent examination against breast cancer cells and comparison with PLGA encapsulated form. J Radioanal Nucl Chem 308, 13–22 (2016). https://doi.org/10.1007/s10967-015-4284-1
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10967-015-4284-1